Resources | Oncofocus

3 minutes ago6 min read

CGT Watch Newsletter: March'25 Edition

Dear Readers, Welcome to our inaugural CGT Watch newsletter! We’re excited to bring you monthly highlights on novel targets, innovative...

Feb 112 min read

“The right target, at the right time, for the right price” …is and always has been a guiding principle for Merck KGaA, as stated by its...

Feb 73 min read

The first-line metastatic Melanoma market is currently dominated by immune checkpoint inhibitors—BMS' Opdivo + Yervoy, Opdualag, Opdivo,...

May 28, 20241 min read

Bladder cancer is the most common malignancy of the urinary tract. As of 2022, Bladder Cancer had an incidence of 614,298 patients...

Apr 25, 20241 min read

Esophageal cancer is the fourteenth most commonly diagnosed cancer and the eighth leading cause of cancer-related death worldwide. The...

Apr 10, 20241 min read

CAR-T therapy has dramatically changed the course of cancer management over the past few years. However, despite this impact, one of the...